When Lower BMI Patients Might Benefit From GLP-1 Therapy People with lower BMIs may pursue GLP-1 medications for legitimate reasons beyond traditional weight loss: managing binge eating disorder, reducing visceral fat while preserving muscle with proper nutrition, improving metabolic health markers like insulin resistance or blood sugar variability, or addressing food noise and compulsive eating patterns
The development of scientific literature exploring this connection will likely shape the trajectory of current and future litigation, potentially affecting settlement negotiations and trial outcomes for cases pending against major manufacturers
[DOI] [PMC free article] [PubMed] [Google Scholar] 116.Frias J.P., Davies M.J., Rosenstock J., Perez Manghi F.C., Fernandez Lando L., Bergman B.K., Liu B., Cui X., Brown K., Pharm.D
Salemi, M
65 1000 1500
However, we recommend a personalized series of injections to achieve and maintain optimal results